| AAS | antibiotic–antimycotic solution |
| AD | Alzheimer’s Disease |
| ALS | amyotrophic lateral sclerosis |
| CNS | central nervous system |
| DIV | days in vitro |
| DMEM | Dulbecco’s Modified Eagle’s Medium |
| EAAT1 | glutamate aspartate transporter 1, GLAST-1 |
| ECM Gel | Extracellular Matrix Gel, Matrigel |
| FBR | fibronectin |
| FBS | fetal bovine serum |
| GS | glutamine synthetase |
| ITS | Insulin-Transferrin-Selenium-A Solution |
| LAM | laminin |
| LPS | lipopolysaccharide |
| MS | multiple sclerosis |
| NG2 cells | oligodendrocyte progenitors |
| OGD | oxygen-glucose deprivation |
| OPCs | oligodendrocyte progenitor cells |
| PFA | paraformaldehyde |
| PLL | poly-L-lysine hydrobromide |
| RT | room temperature |
| TNFα | tumor necrosis factor α |